Washington, DC - In the latest of a series of actions to address the epidemic of youth e-cigarette use, the U.S. Food and Drug Administration today launched “The Real Cost” Youth E-Cigarette Prevention Campaign, a new, comprehensive effort aimed at educating kids about the dangers of e-cigarettes. The campaign targets nearly 10.7 million youth, aged 12-17, who have used e-cigarettes or are open to trying them, and features hard-hitting advertising on digital and social media sites popular among teens, as well as placing posters with e-cigarette prevention messages in high schools across the nation.

Washington, DC - In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability). Risk of dying from a range of causes, including cancer and heart disease, varied and will require further analysis and additional follow-up of study participants. These initial findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial, partially supported by the National Institutes of Health, were published online on September 16, 2018 in three papers in The New England Journal of Medicine.

Washington, DC - I am encouraged to see Senate passage of this vital legislation, which will allow us to dedicate more resources to combating the opioid crisis ravaging our country. Since day one of his Administration, President Trump has made addressing the opioid crisis one of his top priorities, and he has directed his entire Administration to do the same.

Washington, DC - "We must protect the American people, the homeland, and our great American way of life." ~ President Donald J. Trump

Washington, DC - Remarks by President Trump at Hispanic Heritage Month Celebration:

Washington, DC - On Monday, September 17, 2018, the President signed into law: